The Food and Drug Administration (FDA) Has Recently Approved the Drug

Multiple Choice

The Food and Drug Administration (FDA) has recently approved the drug Abilify as a treatment for schizophrenia.This means that

A) Abilify may be used for any symptoms that are related to schizophrenia
B) physicians, in most instances, may prescribe Abilify for any medical condition that they believe is appropriate
C) only adults may be prescribed Abilify
D) physicians will need to confirm with the FDA each time they want to prescribe the medication.